跳至主要内容
临床试验/NCT05567081
NCT05567081已完成2 期

Efficacy of Ultrasound-Guided Deep Perineural Platelet Rich Plasma Versus Corticosteroid Injection in Patients With Ulnar Neuropathy at Elbow, a Comparative Study

Tanta University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Change in ultrasound cross sectional area of ulnar nerve at elbow after injection

研究概览

简要总结

This study was be performed on 60 patients with ulnar neuropathy at elbow diagnosed clinically and by electrophysiology and/or ultrasonography selected from Physical medicine, Rheumatology & Rehabilitation Department, Faculty of Medicine, Tanta University.

Patients were be randomly divided into 2 groups:

Group I: will undergo a single ultrasound-guided deep perineural injection with 3ml PRP at the thickest part of the ulnar nerve. PRP will be prepared by PRP method.

Group II: will undergo a single ultrasound-guided deep perineural injection with 1ml corticosteroid (triamcinolone acetonide, 40mg/mL) mixed with 1ml lidocaine hydrochloride.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with ulnar neuropathy at elbow diagnosed clinically and by electrophysiology and/or ultrasonography.

排除标准

  • Patients with severe ulnar neuropathy at elbow according to Gu's classification. 15
  • Brachial plexopathy, peripheral neuropathy, and cervical radiculopathy.
  • History of recent elbow trauma or operation.
  • Malignant neoplasm.
  • Bleeding Disorders.
  • Factors affecting nerve healing process e.g., tobacco use and systemic corticosteroid administration.
  • Contraindications for PRP injection:
  • Significant renal or hepatic dysfunction.
  • Critical thrombocytopenia.
  • Hemodynamic instability.
  • Septicemia.
  • Local infection at the site of the procedure.
  • Consistent use of nonsteroidal anti-inflammatory drugs within the last two weeks.
  • Local injection at the suspected treatment site within the last month.
  • Recent fever or illness.
  • Hemoglobin level <10 g/dL.
  • Platelet dysfunction disorders.

研究组 & 干预措施

PRP group

Experimental

3 cm of autologous platelet rich plasma injected once around the thickest part of ulnar nerve.

干预措施: PRP (Drug)

Corticosteroid group

Experimental

Triamcinolone Acetonide 40mg/mL (1ml) mixed with 1ml lidocaine hydrochloride injected once around the thickest part of ulnar nerve.

干预措施: Triamcinolone Acetonide 40mg/mL (Drug)

结局指标

主要结局

Change in ultrasound cross sectional area of ulnar nerve at elbow after injection

时间窗: 1, and 3 months after injection

Change in nerve conduction parameters of ulnar nerve at elbow after injection

时间窗: 1 and 3 months after injection

Change in ulnar nerve conduction velocity and CMAP across elbow.

次要结局

  • Number of participants with treatment-related adverse events as assessed by CTCAE v4.0(1 month after injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hajar Anwer Elnagar

Doctor

Tanta University

研究点 (1)

Loading locations...

相似试验